Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and ... [Yahoo! Finance]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Net Product Sales (Q4 2025): $65.4 million, a 41% increase year over year. Tavalise Net Product Sales (Q4 2025): $45.6 million, a 47% increase year over year. Gavreto Net Product Sales (Q4 2025): $10.2 million, a 27% increase year over year. Reslidia Net Product Sales (Q4 2025): $9.6 million, a 29% increase year over year. Total Revenue (Q4 2025): $69.8 million. Net Income (Q4 2025): $268.1 million, compared to $14.3 million in Q4 2024. Cash and Short-term Investments (End of 2025): $155 million, up from $77.3 million at the end of 2024. Full Year Net Product Sales (2025): $232 million, a 60% increase compared to 2024. Full Year Net Income (2025): $367 million, compared to $17.5 million in 2024. 2026 Revenue Guidance: $275 to $290 million. 2026 Net Product Sales Guidance: $255 to $265 million. Warning! GuruFocus has detected 6 Warning Signs with RIGL. Is RIGL fairly valued? Test your thesis with our free DCF calculato
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline Progress [Yahoo! Finance]Yahoo! Finance
- Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates [Yahoo! Finance]Yahoo! Finance
- Rigel Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Rigel Pharma (RIGL) Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
RIGL
Earnings
- 3/3/26 - Beat
RIGL
Analyst Actions
- 1/14/26 - Citigroup Inc.
RIGL
Sec Filings
- 3/3/26 - Form 8-K
- 3/3/26 - Form 10-K
- 2/24/26 - Form 4
- RIGL's page on the SEC website